Company / Operating Income per Share
PUMA BIOTECHNOLOGY, INC. Operating Income per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
$0.66
FY2025
5-year range
-$0.97 / $0.66
FY2021-FY2025
Trend
+33.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income per Share has increased for 6 consecutive years, from $-7.63 in FY2019 to $0.66 in FY2025.
Based on SEC 10-K filings.
0.66 in FY2025.
Improved from $0.03 to $0.66 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- PUMA BIOTECHNOLOGY, INC.'s operating income per share has grown for 6 consecutive years.
- In FY2025, operating income per share increased 33.5% year-over-year.
- Lowest operating income per share in the period was in FY2019.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.66 | +33.5% |
| FY2024 | $0.50 | +1688.5% |
| FY2023 | $0.03 | +103.8% |
| FY2022 | -$0.74 | +24.2% |
| FY2021 | -$0.97 | +59.7% |
| FY2020 | -$2.41 | +68.4% |
| FY2019 | -$7.63 | -3.7% |
| FY2018 | -$7.36 | -12.8% |
| FY2017 | -$6.52 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026